Delivery Order SPE2DB20D1051-SPE2DB24FD7NT
Award Date 3/29/24
Potential Completion Date 4/1/24
Potential Value $1.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,709.61 to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of 4,564,340,251 units of Lidocaine 5% Patch 30s, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,107,006 units of Lidocaine 5% Patch 30s. The $1,808.79 contract has a performance period through March 29, 2024 and does not contain a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $3,148.64 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The order is for the supply of 4557487381 - Lidocaine 5% Patch 30s, a medical product. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that DLA awarded solely to Amerisourcebergen Drug Corp to provide a comprehensive...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,179.12 firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. This delivery order is for the supply of 4,563,310,580 units of 5% lidocaine patches. The contract has a completion date of January 12, 2024. AmerisourceBergen Drug Corp is a prime contractor that has a history of providing pharmaceutical products and medical supplies to support DLA Troop Support Medical programs. This delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a $48,206.78 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of 4,565,244,013 units of Lidocaine 5% Patch 30S. The contract has an ultimate completion date of July 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these essential medical supplies to support military treatment facilities and federal healthcare programs. The contract award is not designated as a set-aside....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,399.62 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, with a performance period through March 14, 2024. This delivery order is issued under a larger, single-award indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $8,238.39 firm-fixed-price contract is for the delivery of 4,564,160,115 units of Lidocaine 5% Patch 30s, with a completion date of April 4, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, a firm fixed price delivery order contract valued at $7,528.53 to provide Lidocaine 5% patches. The contract has a performance period through March 5, 2024 and does not include a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, holds an indefinite delivery contract with a potential value of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,239,630 units of Lidocaine 5% Patches. The $1,097.36 award has a completion date of January 5, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, as a prime contractor, has a history of supplying pharmaceuticals, medical supplies, and distribution services to support DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,952.70 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of 4564110488 - Lidocaine 5% Patch 30S, and has a period of performance through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB24FD7NTDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a $1,243.20 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of 4,564,118,890 units of Lidocaine 5% Patch 30s, a specialty pharmaceutical product, with a period of performance through April 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. No set-aside designations were used for this award.
Generated 6/28/24, 10:11 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 3/29/24 |